One Drop’s digital solution helps people with type 2 diabetes who are at greater risk of health inequalities

Peer-reviewed research and the CDC have found that worse or adverse health outcomes, such as morbidity and mortality, are disproportionately observed in communities of color and those with lower socioeconomic status and limited access to health insurance and quality care [1]. In the context of these health inequalities, the present study examined the effectiveness of One Drop’s digital health program in relation to the risk of health inequalities. Researchers determined each participant’s cumulative risk of unequal health outcomes by counting their approval of five sociodemographic factors: membership of a minority ethnic group, low educational attainment, low household income, lack of insurance, and under- or unemployment [2]. There was a significant association between higher cumulative risk of health inequalities and higher (a) engagement with One Drop’s educational content and (b) ratings of One Drop’s helpfulness. The results suggest that vulnerable people with type 2 diabetes can fill the gaps left by insufficient access to quality healthcare and systemic discrimination by embracing digital healthcare solutions [3].

Earlier this year, One Drop made a commitment to bridge the healthcare gap. Their goal is becoming more relevant as chronic disease rates continue to rise and people from racial and ethnic minorities and groups disadvantaged by poor social health determinants are disproportionately affected.

“At One Drop, we have a unique opportunity to address health inequalities in our research,” said Steven Imrisek, MA, first author and principal outcomes researcher at One Drop. “The trends emerging from this survey are an encouraging sign that digital health tools like One Drop have the potential to have a significant impact on underserved populations who may have limited access to health services or who may be racial, ethnic affiliation, socio-economic status, etc. other factors are discriminated against. We intend to continue investing in inclusive and equitable research processes to ensure those with the greatest needs can reap the benefits of our precision healthcare approach.”

The One Drop evidence generation team presented at ADA 2022 two additional studies examining people with type 2 diabetes, one on cardiovascular disease risk awareness and attitudes and the other on attitudes and acceptance of continuous Glucose Monitoring (CGM). [4,5]. Interest in CGM was high among most respondents, mainly because of a desire to see their numbers in real time and improve their health, although cost and insurance coverage were concerns for some.

A full-time CGM practitioner and person with Type 1 Diabetes, CEO and Founder of One Drop Jeff Dachis sees the benefit of continuous glucose data and believes the technology should be accessible to everyone with diabetes. One Drop is developing a daily, minimally invasive continuous health sensor that aims to offer people with diabetes more flexibility and insight than blood glucose meters (BGM) alone. Availability of this continuous health sensor is subject to clearance or approval by the US Food and Drug Administration.

  1. Lavizzo-Mourey, RJ, Besser, RE, & Williams, DR (2021). Understanding and mitigating health inequities – past, current, and future directions. N Engl. J Med. 2021;384(18):1681-1684. doi:10.1056/nejmp2008628
  2. Lee, DC, Liang, H, & Shi, L (2021). The convergence of race and income disparities in health insurance coverage in The United States. Int J Equity Health 20, 96.
  3. Imrisek SD, Nagra H, Hoy-Rosas J, Lee M, Goldner D, Dachis J, & Sears L (2022, June). Leveling health inequalities through digital health: Associations between risk of health inequalities and satisfaction with diabetes apps. Poster presented at the 82nd Scientific Meeting of the American Diabetes Association, New Orleans, LA.
  4. Imrisek SD, Hoy-Rosas J, Lavaysse L, Lee M, Dachis J, & Sears L (2022, June). Cardiovascular disease risk awareness in people with type 2 diabetes. Poster presented at the 82nd Scientific Meeting of the American Diabetes Association, New Orleans, LA.
  5. Sears, L., Imrisek, SD, Hoy-Rosas, J., Lavaysse L., Lee, M., Chapman, M., & Dachis, J. (2022, June). CGM attitudes and acceptance in people with type 2 diabetes using One Drop. Poster presented at the 82nd Scientific Meeting of the American Diabetes Association, New Orleans, LA.

About a drop
One Drop is a precision healthcare company that combines continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes to people with diabetes and other chronic conditions. The goal: Empower everyone to take proactive actions for better health, peak performance and a more fulfilling life. The Bluetooth Glucose Meter Kit, on-demand testing supplies, and other One Drop products and services are on the One Drop app (iOS and Android) and on, Walmart, Amazon, BestBuy, the Apple Store, and CVS available . A sensor with continuous glucose monitoring capabilities is under development and subject to regulatory approval.


Comments are closed.